JPRN-UMIN000040909
Completed
未知
Study of treatment for esophageal cancer - Study of treatment for esophageal cancer
Graduate School of Medical Sciences,Kyushu University0 sites26 target enrollmentJune 26, 2020
ConditionsEsophageal cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Esophageal cancer
- Sponsor
- Graduate School of Medical Sciences,Kyushu University
- Enrollment
- 26
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •thoracotomy, mediastinal endoscopy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Phase II trial in inoperable œsophageal cancer evaluating the feasibility of the combination of definitive chemoradiation with the immune checkpoint blockers Nivolumab +/- Ipilimumab (CRUCIAL)oesophageal squamous cell carcinoma and oeasophageal adenocarcinomaMedDRA version: 20.0Level: PTClassification code 10061534Term: Oesophageal squamous cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10030137Term: Oesophageal adenocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-000053-53-ESEuropean Organisation for Research and Treatment of Cancer130
Active, not recruiting
Phase 1
Phase II trial in inoperable œsophageal cancer evaluating the feasibility of the combination of definitive chemoradiation with the immune checkpoint blockers Nivolumab +/- Ipilimumab (CRUCIAL)EUCTR2018-000053-53-DEEuropean Organisation for Research and Treatment of Cancer130
Completed
Not Applicable
For advanced or recurrent esophageal cancer Of combination therapy - docetaxel-cisplatin-5 fluorouracil phase I/II trialAdvanced or recurrent esophageal cancerJPRN-UMIN000014625gifu University30
Recruiting
Phase 1
Clinical study on the treatment of gastroesophageal reflux cough by the reverse embedding method of tongdu xuanfeiITMCTR2100004898anjing Hospital of Traditional Chinese Medicine
Not yet recruiting
Phase 1
Juzendaihoto administration for esophageal cancer patientsEsophageal cancerJPRN-UMIN000036616agasaki University35